| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Glycoproteins | 99 | 2020 | 668 | 7.070 |
Why?
|
| Lipopolysaccharides | 105 | 2025 | 630 | 6.260 |
Why?
|
| Receptors, Cell Surface | 73 | 2007 | 431 | 5.390 |
Why?
|
| Toll-Like Receptor 4 | 92 | 2022 | 351 | 4.650 |
Why?
|
| Signal Transduction | 109 | 2022 | 3153 | 3.980 |
Why?
|
| Lipopolysaccharide Receptors | 62 | 2022 | 144 | 3.270 |
Why?
|
| Toll-Like Receptors | 91 | 2020 | 435 | 3.040 |
Why?
|
| Macrophages | 65 | 2019 | 1060 | 2.960 |
Why?
|
| Toll-Like Receptor 2 | 74 | 2014 | 222 | 2.740 |
Why?
|
| Drosophila Proteins | 45 | 2005 | 758 | 2.670 |
Why?
|
| Inflammasomes | 20 | 2026 | 346 | 2.540 |
Why?
|
| Lymphocyte Antigen 96 | 23 | 2015 | 47 | 2.510 |
Why?
|
| Lipid A | 31 | 2010 | 67 | 2.500 |
Why?
|
| Interferon Type I | 9 | 2025 | 196 | 2.350 |
Why?
|
| Immunity, Innate | 40 | 2020 | 818 | 2.330 |
Why?
|
| Myeloid Differentiation Factor 88 | 50 | 2022 | 203 | 2.240 |
Why?
|
| Carrier Proteins | 35 | 2019 | 723 | 2.190 |
Why?
|
| Streptococcus agalactiae | 18 | 2016 | 79 | 2.180 |
Why?
|
| Mice | 185 | 2026 | 11210 | 2.110 |
Why?
|
| Malaria, Falciparum | 8 | 2022 | 231 | 2.070 |
Why?
|
| Animals | 242 | 2026 | 21534 | 2.010 |
Why?
|
| Mice, Knockout | 90 | 2026 | 2149 | 1.930 |
Why?
|
| Malaria | 12 | 2025 | 156 | 1.880 |
Why?
|
| Monocytes | 25 | 2024 | 364 | 1.660 |
Why?
|
| Plasmodium falciparum | 8 | 2022 | 257 | 1.650 |
Why?
|
| Mice, Inbred C57BL | 87 | 2025 | 3468 | 1.590 |
Why?
|
| Cytokines | 42 | 2022 | 956 | 1.530 |
Why?
|
| DNA, Protozoan | 7 | 2017 | 50 | 1.480 |
Why?
|
| Tumor Necrosis Factor-alpha | 43 | 2025 | 623 | 1.430 |
Why?
|
| Toll-Like Receptor 9 | 22 | 2020 | 212 | 1.430 |
Why?
|
| Cell Line | 83 | 2016 | 2068 | 1.420 |
Why?
|
| Alzheimer Disease | 11 | 2025 | 771 | 1.390 |
Why?
|
| Receptors, Immunologic | 29 | 2009 | 178 | 1.370 |
Why?
|
| Neisseria gonorrhoeae | 4 | 2025 | 202 | 1.330 |
Why?
|
| Plasmodium chabaudi | 8 | 2025 | 29 | 1.330 |
Why?
|
| Inflammation | 32 | 2023 | 1186 | 1.270 |
Why?
|
| CHO Cells | 53 | 2009 | 190 | 1.270 |
Why?
|
| Acute-Phase Proteins | 15 | 2006 | 36 | 1.260 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 19 | 2025 | 261 | 1.250 |
Why?
|
| Interleukin-1beta | 19 | 2023 | 273 | 1.250 |
Why?
|
| NF-kappa B | 45 | 2013 | 475 | 1.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 29 | 2022 | 440 | 1.190 |
Why?
|
| Endotoxins | 13 | 2004 | 83 | 1.160 |
Why?
|
| Receptors, Interleukin-1 | 14 | 2016 | 65 | 1.150 |
Why?
|
| Cricetinae | 55 | 2009 | 370 | 1.140 |
Why?
|
| CARD Signaling Adaptor Proteins | 6 | 2026 | 69 | 1.140 |
Why?
|
| Interleukin-10 | 6 | 2025 | 164 | 1.090 |
Why?
|
| Nucleotidyltransferases | 3 | 2017 | 68 | 1.090 |
Why?
|
| Gonorrhea | 3 | 2025 | 160 | 1.000 |
Why?
|
| Humans | 205 | 2025 | 65502 | 0.990 |
Why?
|
| Malaria, Cerebral | 5 | 2020 | 23 | 0.960 |
Why?
|
| Malaria, Vivax | 7 | 2025 | 51 | 0.930 |
Why?
|
| Bacterial Proteins | 20 | 2014 | 788 | 0.920 |
Why?
|
| Dendritic Cells | 23 | 2024 | 534 | 0.890 |
Why?
|
| Antigens, Surface | 12 | 2005 | 200 | 0.890 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2025 | 48 | 0.880 |
Why?
|
| Phagocytosis | 16 | 2019 | 266 | 0.880 |
Why?
|
| Glycolipids | 12 | 2010 | 46 | 0.880 |
Why?
|
| Interferons | 1 | 2025 | 73 | 0.870 |
Why?
|
| Transfection | 38 | 2016 | 707 | 0.860 |
Why?
|
| Antigens, CD | 15 | 2015 | 349 | 0.850 |
Why?
|
| Macrophages, Peritoneal | 13 | 2009 | 76 | 0.820 |
Why?
|
| Antigens, Differentiation | 19 | 2006 | 142 | 0.810 |
Why?
|
| Membrane Proteins | 14 | 2019 | 929 | 0.810 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 12 | 2022 | 81 | 0.800 |
Why?
|
| Interferon-gamma | 13 | 2025 | 582 | 0.800 |
Why?
|
| Macrophage Activation | 14 | 2014 | 118 | 0.780 |
Why?
|
| Inflammation Mediators | 16 | 2019 | 180 | 0.750 |
Why?
|
| Cells, Cultured | 37 | 2017 | 2214 | 0.720 |
Why?
|
| Toll-Like Receptor 7 | 9 | 2020 | 104 | 0.700 |
Why?
|
| Lymphocytes | 2 | 2022 | 204 | 0.700 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 8 | 1995 | 20 | 0.690 |
Why?
|
| DNA-Binding Proteins | 12 | 2014 | 1224 | 0.680 |
Why?
|
| CD18 Antigens | 11 | 2002 | 30 | 0.670 |
Why?
|
| Interferon Regulatory Factor-3 | 14 | 2019 | 98 | 0.670 |
Why?
|
| Plasmodium vivax | 6 | 2025 | 49 | 0.670 |
Why?
|
| Adjuvants, Immunologic | 7 | 2013 | 236 | 0.660 |
Why?
|
| Gene Expression Regulation | 19 | 2020 | 1638 | 0.650 |
Why?
|
| DNA, Bacterial | 6 | 2020 | 271 | 0.650 |
Why?
|
| Interleukin-18 | 4 | 2019 | 76 | 0.640 |
Why?
|
| Microglia | 10 | 2026 | 253 | 0.640 |
Why?
|
| Amyloid beta-Peptides | 6 | 2025 | 320 | 0.630 |
Why?
|
| Hemeproteins | 5 | 2018 | 17 | 0.620 |
Why?
|
| Plasmodium berghei | 3 | 2020 | 21 | 0.600 |
Why?
|
| Toll-Like Receptor 3 | 11 | 2022 | 66 | 0.600 |
Why?
|
| RNA, Bacterial | 3 | 2014 | 76 | 0.580 |
Why?
|
| Antigen-Antibody Complex | 4 | 2015 | 52 | 0.570 |
Why?
|
| Caspase 1 | 11 | 2023 | 111 | 0.560 |
Why?
|
| Lymphocyte Activation | 14 | 2020 | 757 | 0.550 |
Why?
|
| Amyloid | 1 | 2018 | 71 | 0.550 |
Why?
|
| Mutation | 17 | 2016 | 2689 | 0.540 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 4 | 2024 | 34 | 0.530 |
Why?
|
| B-Lymphocytes | 6 | 2014 | 569 | 0.530 |
Why?
|
| Seizures | 1 | 2018 | 141 | 0.530 |
Why?
|
| Protein Binding | 21 | 2017 | 1651 | 0.520 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 152 | 0.520 |
Why?
|
| Mutation, Missense | 3 | 2019 | 189 | 0.520 |
Why?
|
| 5' Untranslated Regions | 1 | 2017 | 29 | 0.510 |
Why?
|
| Lysosomes | 6 | 2014 | 171 | 0.500 |
Why?
|
| CpG Islands | 7 | 2008 | 220 | 0.500 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 88 | 0.490 |
Why?
|
| Neutrophils | 8 | 2015 | 384 | 0.490 |
Why?
|
| MicroRNAs | 3 | 2020 | 710 | 0.480 |
Why?
|
| Lipoproteins | 7 | 2010 | 85 | 0.470 |
Why?
|
| Plasmodium | 4 | 2024 | 33 | 0.470 |
Why?
|
| Anopheles | 3 | 2022 | 23 | 0.470 |
Why?
|
| Molecular Sequence Data | 21 | 2014 | 2016 | 0.460 |
Why?
|
| Streptococcal Infections | 6 | 2016 | 80 | 0.450 |
Why?
|
| Leukocytes, Mononuclear | 10 | 2022 | 247 | 0.440 |
Why?
|
| Amino Acid Substitution | 4 | 2019 | 240 | 0.440 |
Why?
|
| Hemolysin Proteins | 2 | 2014 | 45 | 0.430 |
Why?
|
| Parasitemia | 5 | 2025 | 49 | 0.420 |
Why?
|
| Neisseria meningitidis | 5 | 2006 | 78 | 0.420 |
Why?
|
| Protein Structure, Tertiary | 15 | 2015 | 682 | 0.420 |
Why?
|
| Female | 46 | 2025 | 34105 | 0.410 |
Why?
|
| Membrane Transport Proteins | 7 | 2013 | 139 | 0.410 |
Why?
|
| Recombinant Fusion Proteins | 13 | 2016 | 501 | 0.410 |
Why?
|
| Brain | 5 | 2020 | 1606 | 0.410 |
Why?
|
| Trypanosoma cruzi | 5 | 2020 | 53 | 0.410 |
Why?
|
| Cytoskeletal Proteins | 3 | 2017 | 205 | 0.400 |
Why?
|
| Amino Acid Sequence | 17 | 2014 | 1618 | 0.390 |
Why?
|
| Teichoic Acids | 6 | 2008 | 13 | 0.390 |
Why?
|
| Sepsis | 9 | 2009 | 292 | 0.390 |
Why?
|
| Cell Membrane | 12 | 2014 | 510 | 0.390 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2013 | 6 | 0.390 |
Why?
|
| Arthritis, Infectious | 1 | 2013 | 20 | 0.390 |
Why?
|
| Acne Vulgaris | 1 | 2013 | 24 | 0.380 |
Why?
|
| Gram-Negative Bacteria | 8 | 2013 | 56 | 0.380 |
Why?
|
| Flow Cytometry | 15 | 2016 | 674 | 0.370 |
Why?
|
| Host-Parasite Interactions | 8 | 2019 | 61 | 0.370 |
Why?
|
| Mice, Transgenic | 8 | 2025 | 1308 | 0.360 |
Why?
|
| Ligands | 13 | 2014 | 420 | 0.360 |
Why?
|
| Genes, Reporter | 8 | 2016 | 261 | 0.360 |
Why?
|
| Cryptococcus neoformans | 4 | 2001 | 148 | 0.360 |
Why?
|
| Erythrocytes | 4 | 2017 | 152 | 0.360 |
Why?
|
| Cytoplasm | 3 | 2020 | 284 | 0.360 |
Why?
|
| AT Rich Sequence | 1 | 2011 | 5 | 0.350 |
Why?
|
| Reactive Oxygen Species | 6 | 2017 | 242 | 0.350 |
Why?
|
| Immune Evasion | 3 | 2025 | 71 | 0.350 |
Why?
|
| Endothelium, Vascular | 4 | 2008 | 178 | 0.340 |
Why?
|
| MAP Kinase Signaling System | 6 | 2019 | 235 | 0.340 |
Why?
|
| Bacterial Toxins | 3 | 2020 | 63 | 0.340 |
Why?
|
| Immunity | 2 | 2019 | 109 | 0.340 |
Why?
|
| CD36 Antigens | 4 | 2013 | 27 | 0.340 |
Why?
|
| Interleukin-6 | 12 | 2022 | 325 | 0.330 |
Why?
|
| Oligonucleotides | 2 | 2013 | 228 | 0.330 |
Why?
|
| Vaccines | 1 | 2012 | 102 | 0.330 |
Why?
|
| Escherichia coli | 15 | 2019 | 728 | 0.320 |
Why?
|
| Bacterial Infections | 7 | 2014 | 154 | 0.320 |
Why?
|
| Transcription Factors | 7 | 2009 | 1558 | 0.320 |
Why?
|
| Streptococcus pneumoniae | 7 | 2012 | 67 | 0.320 |
Why?
|
| Macrophage-1 Antigen | 6 | 2000 | 30 | 0.320 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2025 | 53 | 0.310 |
Why?
|
| Mice, Inbred C3H | 17 | 2011 | 174 | 0.310 |
Why?
|
| Streptolysins | 4 | 2006 | 10 | 0.310 |
Why?
|
| Toxoplasmosis | 2 | 2024 | 21 | 0.300 |
Why?
|
| Cell Wall | 5 | 2003 | 122 | 0.300 |
Why?
|
| Chagas Disease | 3 | 2020 | 37 | 0.300 |
Why?
|
| Male | 34 | 2026 | 31057 | 0.300 |
Why?
|
| Nucleotides, Cyclic | 3 | 2017 | 16 | 0.290 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2025 | 645 | 0.290 |
Why?
|
| Phosphorylation | 10 | 2019 | 977 | 0.280 |
Why?
|
| Endoplasmic Reticulum | 5 | 2010 | 179 | 0.280 |
Why?
|
| Salmonella Infections, Animal | 3 | 2002 | 10 | 0.280 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2025 | 74 | 0.280 |
Why?
|
| CD11 Antigens | 5 | 1999 | 16 | 0.280 |
Why?
|
| Antigen Presentation | 3 | 2009 | 242 | 0.270 |
Why?
|
| Chemokines | 6 | 2020 | 97 | 0.270 |
Why?
|
| Peritonitis | 5 | 2016 | 43 | 0.270 |
Why?
|
| NADPH Oxidases | 4 | 2014 | 71 | 0.270 |
Why?
|
| Toll-Like Receptor 8 | 3 | 2020 | 50 | 0.270 |
Why?
|
| Disease Models, Animal | 13 | 2026 | 2295 | 0.270 |
Why?
|
| Interferon Regulatory Factor-7 | 6 | 2013 | 33 | 0.270 |
Why?
|
| Mycobacterium tuberculosis | 6 | 2016 | 421 | 0.260 |
Why?
|
| Asymptomatic Infections | 2 | 2025 | 29 | 0.260 |
Why?
|
| Microscopy, Confocal | 8 | 2019 | 247 | 0.260 |
Why?
|
| RNA, Messenger | 16 | 2020 | 1587 | 0.260 |
Why?
|
| Recombinant Proteins | 12 | 2009 | 713 | 0.250 |
Why?
|
| Interleukin-1 | 11 | 2009 | 156 | 0.250 |
Why?
|
| Mice, Inbred BALB C | 15 | 2016 | 892 | 0.250 |
Why?
|
| In Vitro Techniques | 11 | 2005 | 495 | 0.250 |
Why?
|
| Pneumococcal Infections | 2 | 2005 | 39 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2014 | 551 | 0.250 |
Why?
|
| Hepatitis | 2 | 2023 | 58 | 0.250 |
Why?
|
| Adaptive Immunity | 2 | 2025 | 105 | 0.240 |
Why?
|
| Cognitive Dysfunction | 2 | 2026 | 351 | 0.240 |
Why?
|
| Models, Molecular | 7 | 2017 | 1174 | 0.240 |
Why?
|
| Toll-Like Receptor 6 | 7 | 2009 | 13 | 0.240 |
Why?
|
| Gene Expression Profiling | 8 | 2018 | 800 | 0.240 |
Why?
|
| Chlamydia trachomatis | 2 | 1997 | 60 | 0.240 |
Why?
|
| Enterotoxins | 2 | 2020 | 21 | 0.240 |
Why?
|
| HMGB1 Protein | 3 | 2015 | 26 | 0.240 |
Why?
|
| Head Injuries, Closed | 1 | 2026 | 18 | 0.240 |
Why?
|
| Peptidoglycan | 5 | 2005 | 55 | 0.240 |
Why?
|
| Colitis | 3 | 2020 | 78 | 0.230 |
Why?
|
| Gene Deletion | 6 | 2012 | 316 | 0.230 |
Why?
|
| Alleles | 3 | 2013 | 457 | 0.230 |
Why?
|
| Cathelicidins | 1 | 2025 | 11 | 0.230 |
Why?
|
| Profilins | 1 | 2005 | 45 | 0.230 |
Why?
|
| Interleukin-12 | 7 | 2024 | 128 | 0.230 |
Why?
|
| Platelet Activating Factor | 2 | 2019 | 3 | 0.230 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2019 | 6 | 0.230 |
Why?
|
| Microbial Viability | 2 | 2016 | 58 | 0.220 |
Why?
|
| Up-Regulation | 10 | 2015 | 379 | 0.220 |
Why?
|
| Ethanol | 2 | 2025 | 330 | 0.220 |
Why?
|
| Protein Multimerization | 3 | 2016 | 182 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2017 | 460 | 0.210 |
Why?
|
| Chronic Disease | 2 | 2025 | 757 | 0.210 |
Why?
|
| Staphylococcus aureus | 4 | 2019 | 185 | 0.210 |
Why?
|
| Succinates | 1 | 2024 | 10 | 0.210 |
Why?
|
| Communicable Diseases | 2 | 2017 | 92 | 0.210 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2010 | 252 | 0.210 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 138 | 0.200 |
Why?
|
| Proteolipids | 4 | 2010 | 23 | 0.200 |
Why?
|
| Heme | 2 | 2014 | 30 | 0.200 |
Why?
|
| Molecular Chaperones | 3 | 2020 | 100 | 0.200 |
Why?
|
| Gene Expression | 9 | 2016 | 867 | 0.200 |
Why?
|
| Lysine | 1 | 2003 | 93 | 0.200 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2016 | 46 | 0.200 |
Why?
|
| Interleukin-8 | 9 | 2014 | 94 | 0.190 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2003 | 24 | 0.190 |
Why?
|
| Apoptosis | 8 | 2012 | 1109 | 0.190 |
Why?
|
| Neurodegenerative Diseases | 2 | 2020 | 149 | 0.190 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2022 | 39 | 0.190 |
Why?
|
| Toxoplasma | 4 | 2013 | 34 | 0.190 |
Why?
|
| Endosomes | 5 | 2019 | 180 | 0.190 |
Why?
|
| Base Sequence | 10 | 2010 | 1346 | 0.190 |
Why?
|
| Alcohol Drinking | 1 | 2025 | 322 | 0.190 |
Why?
|
| Phospholipids | 4 | 2010 | 82 | 0.180 |
Why?
|
| Tyrosine | 3 | 2010 | 95 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 511 | 0.180 |
Why?
|
| Immunoblotting | 6 | 2014 | 207 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 14 | 2013 | 877 | 0.180 |
Why?
|
| Immunity, Cellular | 2 | 2017 | 175 | 0.180 |
Why?
|
| Bone Marrow Cells | 5 | 2011 | 238 | 0.180 |
Why?
|
| Species Specificity | 4 | 2010 | 348 | 0.180 |
Why?
|
| Receptors, Interleukin | 5 | 2014 | 38 | 0.180 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2023 | 80 | 0.180 |
Why?
|
| Spleen | 4 | 2020 | 479 | 0.180 |
Why?
|
| Toll-Like Receptor 1 | 5 | 2009 | 22 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 3 | 2014 | 286 | 0.180 |
Why?
|
| Protein Aggregation, Pathological | 2 | 2019 | 20 | 0.180 |
Why?
|
| Gram-Positive Bacteria | 2 | 2013 | 36 | 0.170 |
Why?
|
| Caspase 8 | 2 | 2020 | 66 | 0.170 |
Why?
|
| RNA, Viral | 3 | 2020 | 272 | 0.170 |
Why?
|
| Mycobacterium | 3 | 2004 | 37 | 0.170 |
Why?
|
| Phenotype | 4 | 2013 | 1241 | 0.170 |
Why?
|
| Antigen-Presenting Cells | 3 | 2011 | 180 | 0.170 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 2013 | 245 | 0.170 |
Why?
|
| Fimbriae, Bacterial | 2 | 2012 | 19 | 0.170 |
Why?
|
| Cell Separation | 5 | 2011 | 148 | 0.170 |
Why?
|
| HEK293 Cells | 5 | 2019 | 630 | 0.170 |
Why?
|
| Chlamydia Infections | 2 | 2005 | 79 | 0.170 |
Why?
|
| Receptors, IgG | 2 | 2014 | 41 | 0.160 |
Why?
|
| Schools | 1 | 2021 | 170 | 0.160 |
Why?
|
| Receptors, CXCR3 | 1 | 2020 | 35 | 0.160 |
Why?
|
| Arachidonic Acid | 3 | 1995 | 38 | 0.160 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2016 | 119 | 0.160 |
Why?
|
| Antigens, Bacterial | 6 | 2009 | 202 | 0.160 |
Why?
|
| Nucleic Acids | 3 | 2013 | 60 | 0.160 |
Why?
|
| Endogenous Retroviruses | 1 | 2020 | 12 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2020 | 681 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2005 | 49 | 0.160 |
Why?
|
| NIMA-Related Kinases | 1 | 2019 | 5 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2013 | 219 | 0.160 |
Why?
|
| Clostridium Infections | 1 | 2020 | 49 | 0.150 |
Why?
|
| Survival Analysis | 4 | 2015 | 589 | 0.150 |
Why?
|
| Myelin Proteins | 3 | 2010 | 30 | 0.150 |
Why?
|
| Virulence Factors | 4 | 2014 | 86 | 0.150 |
Why?
|
| Growth Substances | 1 | 1999 | 34 | 0.150 |
Why?
|
| Protein Conformation | 5 | 2007 | 792 | 0.150 |
Why?
|
| Cricetulus | 9 | 2009 | 101 | 0.150 |
Why?
|
| Antimalarials | 2 | 2018 | 129 | 0.150 |
Why?
|
| Toxoplasmosis, Animal | 2 | 2010 | 10 | 0.150 |
Why?
|
| Integrin alphaXbeta2 | 2 | 1998 | 3 | 0.150 |
Why?
|
| Heat-Shock Proteins | 1 | 1999 | 69 | 0.150 |
Why?
|
| Models, Immunological | 5 | 2013 | 86 | 0.150 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 969 | 0.150 |
Why?
|
| Mice, Mutant Strains | 4 | 2019 | 302 | 0.150 |
Why?
|
| Th1 Cells | 3 | 2025 | 173 | 0.150 |
Why?
|
| Liver | 5 | 2018 | 878 | 0.150 |
Why?
|
| Malaria Vaccines | 2 | 2019 | 40 | 0.140 |
Why?
|
| Mice, Inbred DBA | 3 | 2015 | 85 | 0.140 |
Why?
|
| Piracetam | 1 | 2018 | 8 | 0.140 |
Why?
|
| Blotting, Western | 6 | 2015 | 619 | 0.140 |
Why?
|
| Enzyme Activation | 9 | 2020 | 392 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2012 | 880 | 0.140 |
Why?
|
| Fungal Proteins | 1 | 1999 | 152 | 0.140 |
Why?
|
| Immune Tolerance | 3 | 2006 | 181 | 0.140 |
Why?
|
| Interleukin-33 | 1 | 2018 | 19 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 4 | 2012 | 71 | 0.140 |
Why?
|
| Autoimmune Diseases | 2 | 2013 | 242 | 0.140 |
Why?
|
| tau Proteins | 1 | 2019 | 209 | 0.140 |
Why?
|
| Escherichia coli Infections | 3 | 2003 | 90 | 0.140 |
Why?
|
| Porphyromonas gingivalis | 4 | 2008 | 17 | 0.140 |
Why?
|
| Fibroblasts | 8 | 2006 | 421 | 0.140 |
Why?
|
| Dinucleoside Phosphates | 2 | 2016 | 32 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.140 |
Why?
|
| Mutagenesis | 1 | 1998 | 133 | 0.140 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1998 | 14 | 0.140 |
Why?
|
| Adolescent | 7 | 2021 | 6361 | 0.140 |
Why?
|
| Antibodies, Bacterial | 3 | 2013 | 183 | 0.140 |
Why?
|
| Leukocytes | 2 | 2018 | 104 | 0.140 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 376 | 0.140 |
Why?
|
| RNA, Protozoan | 2 | 2014 | 10 | 0.130 |
Why?
|
| Ceramides | 1 | 2017 | 24 | 0.130 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2010 | 279 | 0.130 |
Why?
|
| Hemolysis | 2 | 2014 | 41 | 0.130 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 39 | 0.130 |
Why?
|
| Granulocytes | 2 | 2015 | 73 | 0.130 |
Why?
|
| Adult | 14 | 2025 | 17399 | 0.130 |
Why?
|
| Chromatin | 1 | 2022 | 643 | 0.130 |
Why?
|
| Receptors, Complement | 1 | 1997 | 16 | 0.130 |
Why?
|
| Nod2 Signaling Adaptor Protein | 2 | 2014 | 26 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 205 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 208 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 222 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2017 | 90 | 0.130 |
Why?
|
| Lipoproteins, LDL | 5 | 2013 | 49 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2017 | 146 | 0.130 |
Why?
|
| Phagosomes | 2 | 2014 | 54 | 0.120 |
Why?
|
| Pyrophosphatases | 1 | 2016 | 11 | 0.120 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2016 | 8 | 0.120 |
Why?
|
| Atherosclerosis | 3 | 2013 | 160 | 0.120 |
Why?
|
| Bacterial Secretion Systems | 1 | 2016 | 12 | 0.120 |
Why?
|
| Pyrin | 1 | 2016 | 7 | 0.120 |
Why?
|
| Familial Mediterranean Fever | 1 | 2016 | 9 | 0.120 |
Why?
|
| Mitochondria | 2 | 2024 | 404 | 0.120 |
Why?
|
| Immunoprecipitation | 3 | 2011 | 129 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 350 | 0.120 |
Why?
|
| Models, Biological | 5 | 2014 | 1217 | 0.120 |
Why?
|
| Interferon-beta | 4 | 2010 | 79 | 0.120 |
Why?
|
| Solubility | 4 | 2014 | 192 | 0.120 |
Why?
|
| Protein Transport | 3 | 2019 | 413 | 0.120 |
Why?
|
| Nitric Oxide | 4 | 2011 | 181 | 0.120 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2015 | 3 | 0.120 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2015 | 9 | 0.120 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2015 | 6 | 0.120 |
Why?
|
| Apolipoprotein A-I | 1 | 2015 | 23 | 0.120 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2016 | 72 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 705 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2005 | 369 | 0.120 |
Why?
|
| Lipopeptides | 3 | 2014 | 15 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 219 | 0.120 |
Why?
|
| Lung | 5 | 2008 | 972 | 0.120 |
Why?
|
| Kidney | 6 | 2007 | 455 | 0.120 |
Why?
|
| Candida albicans | 1 | 1996 | 75 | 0.120 |
Why?
|
| Brazil | 3 | 2022 | 105 | 0.120 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2016 | 44 | 0.110 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1995 | 5 | 0.110 |
Why?
|
| Receptors, Complement 3b | 2 | 2014 | 12 | 0.110 |
Why?
|
| Iron | 1 | 2016 | 155 | 0.110 |
Why?
|
| Fimbriae Proteins | 2 | 2012 | 14 | 0.110 |
Why?
|
| T-Lymphocytes | 5 | 2010 | 1012 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2009 | 154 | 0.110 |
Why?
|
| Binding Sites | 4 | 2009 | 930 | 0.110 |
Why?
|
| Vasculitis | 2 | 2005 | 50 | 0.110 |
Why?
|
| Shock, Septic | 4 | 2014 | 87 | 0.110 |
Why?
|
| Metalloproteases | 1 | 2014 | 4 | 0.110 |
Why?
|
| Young Adult | 5 | 2017 | 4815 | 0.110 |
Why?
|
| Protein Isoforms | 5 | 2013 | 204 | 0.110 |
Why?
|
| Complement Factor H | 1 | 2016 | 118 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 134 | 0.110 |
Why?
|
| Glycosylphosphatidylinositols | 2 | 2007 | 24 | 0.110 |
Why?
|
| Phagocytes | 2 | 1994 | 52 | 0.110 |
Why?
|
| Biological Transport, Active | 3 | 2015 | 38 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 334 | 0.110 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 132 | 0.110 |
Why?
|
| Aging | 2 | 2019 | 766 | 0.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2012 | 143 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 390 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2007 | 172 | 0.110 |
Why?
|
| Polymyxin B | 2 | 2004 | 11 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 2 | 2024 | 44 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2018 | 2068 | 0.110 |
Why?
|
| Chlamydophila pneumoniae | 3 | 2005 | 22 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 406 | 0.110 |
Why?
|
| Histones | 1 | 2018 | 499 | 0.110 |
Why?
|
| Astrocytes | 3 | 2015 | 122 | 0.110 |
Why?
|
| Fatty Acids | 2 | 2010 | 205 | 0.100 |
Why?
|
| Time Factors | 7 | 2020 | 3785 | 0.100 |
Why?
|
| Porins | 2 | 2006 | 63 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 134 | 0.100 |
Why?
|
| Child | 3 | 2021 | 4666 | 0.100 |
Why?
|
| RNA, Double-Stranded | 2 | 2005 | 111 | 0.100 |
Why?
|
| Animals, Newborn | 4 | 2008 | 245 | 0.100 |
Why?
|
| Cysteine | 2 | 2005 | 108 | 0.100 |
Why?
|
| Chemokine CCL5 | 4 | 2009 | 33 | 0.100 |
Why?
|
| Kinetics | 6 | 2009 | 768 | 0.100 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 84 | 0.100 |
Why?
|
| Rhodobacter sphaeroides | 4 | 2000 | 8 | 0.100 |
Why?
|
| Acetylglucosamine | 1 | 2013 | 10 | 0.100 |
Why?
|
| Dimerization | 2 | 2013 | 147 | 0.100 |
Why?
|
| Insect Vectors | 1 | 2013 | 15 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 2 | 2010 | 101 | 0.100 |
Why?
|
| Drosophila | 4 | 2005 | 481 | 0.100 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2014 | 82 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2016 | 272 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2015 | 143 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 1993 | 93 | 0.100 |
Why?
|
| Turpentine | 1 | 2013 | 2 | 0.100 |
Why?
|
| Genome, Insect | 1 | 2013 | 40 | 0.100 |
Why?
|
| Leishmania major | 1 | 2013 | 8 | 0.100 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2013 | 16 | 0.100 |
Why?
|
| Artemisia annua | 1 | 2012 | 7 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2013 | 72 | 0.100 |
Why?
|
| Autophagy | 2 | 2016 | 237 | 0.100 |
Why?
|
| Infant | 1 | 2018 | 1704 | 0.100 |
Why?
|
| Plants, Medicinal | 1 | 2012 | 61 | 0.090 |
Why?
|
| Syndrome | 1 | 2013 | 178 | 0.090 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2005 | 30 | 0.090 |
Why?
|
| Prions | 1 | 2012 | 27 | 0.090 |
Why?
|
| Mycoses | 1 | 2013 | 71 | 0.090 |
Why?
|
| Golgi Apparatus | 2 | 2003 | 65 | 0.090 |
Why?
|
| TNF Receptor-Associated Factor 6 | 2 | 2009 | 26 | 0.090 |
Why?
|
| Empiricism | 1 | 2012 | 3 | 0.090 |
Why?
|
| Tumor Necrosis Factors | 1 | 2012 | 8 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 215 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 112 | 0.090 |
Why?
|
| Staphylococcus epidermidis | 2 | 2010 | 11 | 0.090 |
Why?
|
| Cloning, Molecular | 3 | 2005 | 388 | 0.090 |
Why?
|
| Nerve Degeneration | 1 | 2012 | 72 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 62 | 0.090 |
Why?
|
| Communicable Disease Control | 1 | 2012 | 43 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 214 | 0.090 |
Why?
|
| Memory | 1 | 2012 | 123 | 0.090 |
Why?
|
| Cell Movement | 3 | 2020 | 478 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 3 | 2012 | 65 | 0.090 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2013 | 170 | 0.090 |
Why?
|
| Leishmania guyanensis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 923 | 0.090 |
Why?
|
| Microsporidiosis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Potassium | 3 | 2019 | 103 | 0.090 |
Why?
|
| Enterocytozoon | 1 | 2011 | 2 | 0.090 |
Why?
|
| Middle Aged | 7 | 2021 | 18271 | 0.090 |
Why?
|
| Neurons | 3 | 2012 | 949 | 0.090 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2011 | 2 | 0.090 |
Why?
|
| Oligopeptides | 3 | 2007 | 135 | 0.090 |
Why?
|
| Injections, Intraperitoneal | 4 | 2004 | 47 | 0.090 |
Why?
|
| Bacteria | 2 | 2006 | 338 | 0.090 |
Why?
|
| RNA Interference | 4 | 2015 | 642 | 0.080 |
Why?
|
| Epithelial Cells | 3 | 2014 | 419 | 0.080 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 104 | 0.080 |
Why?
|
| Blood Proteins | 3 | 1999 | 84 | 0.080 |
Why?
|
| Carbohydrate Conformation | 4 | 2005 | 16 | 0.080 |
Why?
|
| Intracellular Fluid | 4 | 2003 | 32 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2012 | 238 | 0.080 |
Why?
|
| Chimera | 2 | 2003 | 46 | 0.080 |
Why?
|
| Antibodies | 3 | 2017 | 188 | 0.080 |
Why?
|
| Sheep | 2 | 1988 | 190 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2008 | 181 | 0.080 |
Why?
|
| Dose-Response Relationship, Immunologic | 6 | 2007 | 50 | 0.080 |
Why?
|
| Aspartic Acid | 1 | 2010 | 34 | 0.080 |
Why?
|
| Receptor for Advanced Glycation End Products | 2 | 2007 | 21 | 0.080 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2008 | 88 | 0.080 |
Why?
|
| Vaccinia virus | 1 | 2010 | 72 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 466 | 0.080 |
Why?
|
| Genetic Complementation Test | 2 | 2001 | 68 | 0.080 |
Why?
|
| Rats | 5 | 2013 | 2018 | 0.080 |
Why?
|
| Yersinia pseudotuberculosis Infections | 1 | 2009 | 1 | 0.080 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2009 | 3 | 0.080 |
Why?
|
| Leucine | 1 | 2010 | 67 | 0.080 |
Why?
|
| Molecular Structure | 4 | 2017 | 395 | 0.080 |
Why?
|
| Immunologic Memory | 1 | 2012 | 290 | 0.080 |
Why?
|
| Immunophenotyping | 4 | 2015 | 196 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 3 | 2013 | 405 | 0.080 |
Why?
|
| Static Electricity | 1 | 2010 | 169 | 0.080 |
Why?
|
| HIV Seropositivity | 2 | 1995 | 83 | 0.080 |
Why?
|
| Transcriptome | 3 | 2020 | 410 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 3 | 2013 | 378 | 0.080 |
Why?
|
| Insect Proteins | 3 | 2013 | 82 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2021 | 2626 | 0.080 |
Why?
|
| Lipids | 2 | 2009 | 328 | 0.080 |
Why?
|
| Arginine | 1 | 2010 | 134 | 0.080 |
Why?
|
| Phosphates | 2 | 2007 | 100 | 0.080 |
Why?
|
| Steroid Hydroxylases | 1 | 2009 | 11 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 369 | 0.080 |
Why?
|
| Antigens, Helminth | 1 | 2009 | 9 | 0.080 |
Why?
|
| Crystallography, X-Ray | 2 | 2007 | 442 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Bacteroides fragilis | 1 | 2009 | 5 | 0.070 |
Why?
|
| DNA Primers | 3 | 2007 | 301 | 0.070 |
Why?
|
| Bacteremia | 1 | 2010 | 94 | 0.070 |
Why?
|
| Metalloendopeptidases | 1 | 2009 | 21 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 793 | 0.070 |
Why?
|
| Macrophages, Alveolar | 4 | 2007 | 67 | 0.070 |
Why?
|
| Antigens, Protozoan | 3 | 2019 | 61 | 0.070 |
Why?
|
| Helminth Proteins | 1 | 2009 | 51 | 0.070 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2008 | 52 | 0.070 |
Why?
|
| Sex Work | 1 | 1988 | 21 | 0.070 |
Why?
|
| Ascitic Fluid | 3 | 2003 | 12 | 0.070 |
Why?
|
| Culture Media | 2 | 2003 | 80 | 0.070 |
Why?
|
| Bacteroides Infections | 2 | 2009 | 5 | 0.070 |
Why?
|
| Pneumonia, Bacterial | 2 | 2008 | 90 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2010 | 270 | 0.070 |
Why?
|
| Dental Plaque | 1 | 2008 | 5 | 0.070 |
Why?
|
| Gingivitis | 1 | 2008 | 7 | 0.070 |
Why?
|
| Ticarcillin | 1 | 1988 | 3 | 0.070 |
Why?
|
| Transferases | 1 | 2008 | 17 | 0.070 |
Why?
|
| Penicillins | 1 | 1988 | 31 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2013 | 211 | 0.070 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2008 | 37 | 0.070 |
Why?
|
| Periodontitis | 1 | 2008 | 15 | 0.070 |
Why?
|
| NADPH Oxidase 2 | 3 | 2014 | 36 | 0.070 |
Why?
|
| Arthritis, Experimental | 1 | 2008 | 30 | 0.070 |
Why?
|
| Cathepsins | 1 | 2008 | 34 | 0.070 |
Why?
|
| Mucin-1 | 1 | 2007 | 14 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 5619 | 0.070 |
Why?
|
| Acute Disease | 3 | 2017 | 676 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 2 | 2006 | 46 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 742 | 0.070 |
Why?
|
| Liver Abscess | 1 | 1987 | 18 | 0.070 |
Why?
|
| Biological Transport | 3 | 1998 | 295 | 0.070 |
Why?
|
| Cell Survival | 4 | 2014 | 600 | 0.070 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2007 | 4 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 274 | 0.070 |
Why?
|
| Peru | 2 | 2022 | 13 | 0.070 |
Why?
|
| Myositis | 1 | 1987 | 5 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 1614 | 0.070 |
Why?
|
| Salmonella typhimurium | 3 | 2002 | 86 | 0.070 |
Why?
|
| Zymosan | 2 | 2004 | 25 | 0.070 |
Why?
|
| Hyaluronan Receptors | 1 | 2007 | 35 | 0.060 |
Why?
|
| Blood | 2 | 2021 | 31 | 0.060 |
Why?
|
| Onchocerca volvulus | 1 | 2007 | 3 | 0.060 |
Why?
|
| Allosteric Regulation | 1 | 2007 | 71 | 0.060 |
Why?
|
| Brugia malayi | 1 | 2007 | 23 | 0.060 |
Why?
|
| Wolbachia | 1 | 2007 | 5 | 0.060 |
Why?
|
| I-kappa B Kinase | 4 | 2013 | 50 | 0.060 |
Why?
|
| Melanoma, Experimental | 1 | 2007 | 44 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2003 | 78 | 0.060 |
Why?
|
| Obesity | 1 | 2015 | 1269 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2009 | 486 | 0.060 |
Why?
|
| Sulfonamides | 2 | 2019 | 138 | 0.060 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2006 | 13 | 0.060 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2006 | 36 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 1987 | 97 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2007 | 70 | 0.060 |
Why?
|
| Myristic Acid | 1 | 2006 | 8 | 0.060 |
Why?
|
| Uric Acid | 1 | 2006 | 48 | 0.060 |
Why?
|
| Aged | 5 | 2014 | 14955 | 0.060 |
Why?
|
| Trypsin | 1 | 2006 | 43 | 0.060 |
Why?
|
| Cell Line, Transformed | 3 | 2011 | 100 | 0.060 |
Why?
|
| Dengue Virus | 1 | 2006 | 99 | 0.060 |
Why?
|
| Cryptosporidium parvum | 1 | 2006 | 8 | 0.060 |
Why?
|
| Gout | 1 | 2006 | 48 | 0.060 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 10 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 726 | 0.060 |
Why?
|
| Cryptosporidiosis | 1 | 2006 | 10 | 0.060 |
Why?
|
| Bordetella Infections | 1 | 2005 | 2 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2004 | 71 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2006 | 142 | 0.060 |
Why?
|
| Virulence | 3 | 2013 | 199 | 0.060 |
Why?
|
| Virus Replication | 1 | 2007 | 324 | 0.060 |
Why?
|
| Propionibacterium | 1 | 2005 | 5 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2013 | 306 | 0.060 |
Why?
|
| Wound Healing | 1 | 2007 | 196 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2004 | 125 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 138 | 0.060 |
Why?
|
| Leptospira interrogans | 1 | 2005 | 3 | 0.060 |
Why?
|
| Enterovirus B, Human | 1 | 2005 | 17 | 0.060 |
Why?
|
| Coxsackievirus Infections | 1 | 2005 | 12 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 3 | 2013 | 46 | 0.060 |
Why?
|
| Protein Methyltransferases | 1 | 2005 | 14 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 47 | 0.060 |
Why?
|
| Hexuronic Acids | 2 | 2002 | 23 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 97 | 0.060 |
Why?
|
| Influenza A virus | 1 | 2006 | 126 | 0.060 |
Why?
|
| Epithelium, Corneal | 1 | 2005 | 7 | 0.060 |
Why?
|
| Keratitis | 1 | 2005 | 11 | 0.060 |
Why?
|
| Alanine | 1 | 2005 | 51 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 41 | 0.060 |
Why?
|
| Pneumonia | 2 | 2006 | 293 | 0.060 |
Why?
|
| Central Nervous System Depressants | 1 | 2025 | 46 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2004 | 328 | 0.060 |
Why?
|
| Coxiella burnetii | 1 | 2004 | 1 | 0.060 |
Why?
|
| Disaccharides | 2 | 1997 | 11 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 39 | 0.060 |
Why?
|
| Electroporation | 1 | 2005 | 36 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 122 | 0.060 |
Why?
|
| Viral Core Proteins | 1 | 2004 | 30 | 0.050 |
Why?
|
| HIV Infections | 2 | 2009 | 965 | 0.050 |
Why?
|
| Rhodococcus equi | 1 | 2004 | 1 | 0.050 |
Why?
|
| Biological Assay | 1 | 2005 | 59 | 0.050 |
Why?
|
| Myelin and Lymphocyte-Associated Proteolipid Proteins | 3 | 2010 | 11 | 0.050 |
Why?
|
| Intestines | 1 | 2006 | 176 | 0.050 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2004 | 28 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2006 | 246 | 0.050 |
Why?
|
| Clone Cells | 2 | 2001 | 115 | 0.050 |
Why?
|
| Klebsiella Infections | 1 | 2004 | 22 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2004 | 30 | 0.050 |
Why?
|
| Myocarditis | 1 | 2005 | 71 | 0.050 |
Why?
|
| Mycoplasma salivarium | 1 | 2004 | 1 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2019 | 80 | 0.050 |
Why?
|
| Haemophilus Vaccines | 1 | 2004 | 4 | 0.050 |
Why?
|
| Bacteroides | 1 | 2004 | 9 | 0.050 |
Why?
|
| Hot Temperature | 4 | 2003 | 144 | 0.050 |
Why?
|
| Mycoplasma fermentans | 2 | 2004 | 2 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 32 | 0.050 |
Why?
|
| Diglycerides | 1 | 2004 | 24 | 0.050 |
Why?
|
| DNA | 4 | 2008 | 855 | 0.050 |
Why?
|
| Periodontal Diseases | 1 | 2004 | 17 | 0.050 |
Why?
|
| Genotype | 3 | 2016 | 679 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 249 | 0.050 |
Why?
|
| Polysaccharides | 2 | 2006 | 154 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2004 | 94 | 0.050 |
Why?
|
| Brucella Vaccine | 1 | 2003 | 1 | 0.050 |
Why?
|
| Biotinylation | 1 | 2003 | 36 | 0.050 |
Why?
|
| Brucella abortus | 1 | 2003 | 6 | 0.050 |
Why?
|
| Luciferases | 3 | 2013 | 109 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 60 | 0.050 |
Why?
|
| Amphotericin B | 1 | 2003 | 23 | 0.050 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 60 | 0.050 |
Why?
|
| Chemokines, CXC | 2 | 2005 | 33 | 0.050 |
Why?
|
| Neutropenia | 2 | 2002 | 68 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 110 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2024 | 88 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2004 | 139 | 0.050 |
Why?
|
| Cell Nucleus | 5 | 2002 | 639 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2004 | 152 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 2 | 1993 | 10 | 0.050 |
Why?
|
| Disease Resistance | 2 | 2013 | 26 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2003 | 166 | 0.050 |
Why?
|
| Schistosoma mansoni | 1 | 2002 | 6 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 820 | 0.050 |
Why?
|
| Mosquito Vectors | 1 | 2022 | 17 | 0.050 |
Why?
|
| CD11b Antigen | 1 | 2002 | 19 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 66 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2002 | 26 | 0.050 |
Why?
|
| Cholesterol | 1 | 2004 | 263 | 0.050 |
Why?
|
| Pulmonary Surfactants | 1 | 2002 | 12 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2003 | 135 | 0.050 |
Why?
|
| Enteritis | 1 | 2002 | 13 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 95 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 91 | 0.050 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 26 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 157 | 0.050 |
Why?
|
| Immunization | 2 | 2015 | 137 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 2 | 2013 | 74 | 0.050 |
Why?
|
| Capnocytophaga | 1 | 2002 | 1 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2002 | 50 | 0.050 |
Why?
|
| Aspergillus fumigatus | 1 | 2002 | 54 | 0.050 |
Why?
|
| Biological Factors | 1 | 2001 | 21 | 0.040 |
Why?
|
| Educational Personnel | 1 | 2021 | 8 | 0.040 |
Why?
|
| Chaperonin 60 | 1 | 2001 | 19 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2014 | 461 | 0.040 |
Why?
|
| Biopolymers | 1 | 2002 | 71 | 0.040 |
Why?
|
| Disulfides | 2 | 2015 | 66 | 0.040 |
Why?
|
| Acyltransferases | 1 | 2001 | 33 | 0.040 |
Why?
|
| Peptides | 3 | 2015 | 603 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2002 | 198 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2002 | 376 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 141 | 0.040 |
Why?
|
| Calcium | 2 | 2019 | 589 | 0.040 |
Why?
|
| Carbohydrate Sequence | 2 | 2005 | 22 | 0.040 |
Why?
|
| Opsonin Proteins | 2 | 2013 | 30 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 449 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 214 | 0.040 |
Why?
|
| Peritoneum | 1 | 2001 | 31 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 906 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 198 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2011 | 1445 | 0.040 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2000 | 18 | 0.040 |
Why?
|
| Structure-Activity Relationship | 3 | 2004 | 388 | 0.040 |
Why?
|
| Amino Acid Motifs | 2 | 2012 | 157 | 0.040 |
Why?
|
| Transcription Factor RelA | 2 | 2014 | 49 | 0.040 |
Why?
|
| Alginates | 1 | 2000 | 50 | 0.040 |
Why?
|
| Protein Folding | 2 | 2015 | 268 | 0.040 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2000 | 10 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 302 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2002 | 54 | 0.040 |
Why?
|
| Mycobacterium avium | 1 | 1999 | 5 | 0.040 |
Why?
|
| Listeria monocytogenes | 1 | 2000 | 34 | 0.040 |
Why?
|
| Molecular Mimicry | 1 | 2000 | 31 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Treponema pallidum | 1 | 1999 | 5 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2013 | 64 | 0.040 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1999 | 30 | 0.040 |
Why?
|
| Indenes | 1 | 2019 | 15 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 23 | 0.040 |
Why?
|
| Sulfones | 1 | 2019 | 42 | 0.040 |
Why?
|
| Plasmids | 4 | 2005 | 297 | 0.040 |
Why?
|
| Furans | 1 | 2019 | 33 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2019 | 20 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2019 | 55 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2009 | 344 | 0.040 |
Why?
|
| Foam Cells | 1 | 1999 | 5 | 0.040 |
Why?
|
| Gingiva | 3 | 2004 | 8 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 146 | 0.040 |
Why?
|
| Students | 1 | 2021 | 226 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 112 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 105 | 0.040 |
Why?
|
| Blood Bactericidal Activity | 1 | 1999 | 61 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2019 | 17 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 23 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 384 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 101 | 0.040 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2019 | 22 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 167 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1999 | 116 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 80 | 0.040 |
Why?
|
| Immunoglobulin M | 2 | 1997 | 113 | 0.040 |
Why?
|
| Paclitaxel | 1 | 1999 | 103 | 0.040 |
Why?
|
| Cell Fusion | 1 | 1998 | 39 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2009 | 42 | 0.040 |
Why?
|
| Trophozoites | 1 | 2018 | 6 | 0.040 |
Why?
|
| Bordetella pertussis | 2 | 2005 | 9 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 1998 | 59 | 0.040 |
Why?
|
| Receptors, LDL | 2 | 1999 | 35 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 94 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2018 | 64 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 49 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 2 | 2011 | 17 | 0.030 |
Why?
|
| Heart | 1 | 2020 | 295 | 0.030 |
Why?
|
| Endocytosis | 1 | 2019 | 153 | 0.030 |
Why?
|
| Spatial Memory | 1 | 2017 | 8 | 0.030 |
Why?
|
| Protein Kinases | 2 | 2013 | 153 | 0.030 |
Why?
|
| Chemistry | 2 | 1988 | 31 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 2017 | 32 | 0.030 |
Why?
|
| Chemical Phenomena | 2 | 1988 | 97 | 0.030 |
Why?
|
| Presenilin-1 | 1 | 2017 | 68 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2018 | 64 | 0.030 |
Why?
|
| Spectrometry, Mass, Secondary Ion | 1 | 1997 | 7 | 0.030 |
Why?
|
| Eating | 1 | 2018 | 140 | 0.030 |
Why?
|
| Methylation | 2 | 2009 | 134 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 91 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 1998 | 195 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 206 | 0.030 |
Why?
|
| Lewis X Antigen | 1 | 1997 | 6 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 706 | 0.030 |
Why?
|
| Protein Domains | 1 | 2017 | 155 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1996 | 14 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1996 | 13 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2017 | 100 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 235 | 0.030 |
Why?
|
| Biotransformation | 1 | 2016 | 25 | 0.030 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2016 | 4 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 2009 | 162 | 0.030 |
Why?
|
| Receptors, Interferon | 1 | 2016 | 20 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 403 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 260 | 0.030 |
Why?
|
| Liver X Receptors | 1 | 2015 | 8 | 0.030 |
Why?
|
| Bacterial Adhesion | 2 | 2000 | 64 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 312 | 0.030 |
Why?
|
| Hippocampus | 1 | 2017 | 280 | 0.030 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2015 | 12 | 0.030 |
Why?
|
| Aggregatibacter actinomycetemcomitans | 2 | 2008 | 4 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 180 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 468 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 191 | 0.030 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1995 | 59 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 122 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 94 | 0.030 |
Why?
|
| Thromboplastin | 1 | 1995 | 6 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 87 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 94 | 0.030 |
Why?
|
| Cell Death | 2 | 2007 | 290 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 676 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 395 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1995 | 46 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2015 | 13 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 197 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 478 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 24 | 0.030 |
Why?
|
| Fluorocarbons | 1 | 2015 | 50 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2014 | 8 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1997 | 322 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2015 | 117 | 0.030 |
Why?
|
| ADAM10 Protein | 1 | 2014 | 11 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1997 | 347 | 0.030 |
Why?
|
| B7-2 Antigen | 2 | 2006 | 32 | 0.030 |
Why?
|
| Hydroquinones | 1 | 1994 | 8 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2014 | 36 | 0.030 |
Why?
|
| Protoporphyrins | 1 | 2014 | 9 | 0.030 |
Why?
|
| Receptors, Interleukin-18 | 2 | 2007 | 9 | 0.030 |
Why?
|
| Salmonella | 1 | 1995 | 45 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 1999 | 557 | 0.030 |
Why?
|
| Aorta | 2 | 2005 | 114 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 77 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2009 | 198 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 57 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 157 | 0.030 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 53 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 3 | 2005 | 697 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 694 | 0.030 |
Why?
|
| Neutrophil Infiltration | 2 | 2005 | 62 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2696 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2015 | 57 | 0.030 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 2014 | 3 | 0.030 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2014 | 5 | 0.030 |
Why?
|
| Phenylenediamines | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mycobacterium smegmatis | 2 | 2005 | 72 | 0.030 |
Why?
|
| Ileum | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 41 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3344 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2014 | 30 | 0.030 |
Why?
|
| Receptors, Scavenger | 1 | 1993 | 9 | 0.030 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2013 | 16 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 228 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2014 | 148 | 0.030 |
Why?
|
| Calcitriol | 1 | 1993 | 25 | 0.030 |
Why?
|
| Viral Fusion Proteins | 2 | 2006 | 54 | 0.030 |
Why?
|
| Caspases | 2 | 2005 | 180 | 0.030 |
Why?
|
| Synteny | 1 | 2013 | 24 | 0.030 |
Why?
|
| Chromosomes, Insect | 1 | 2013 | 10 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2005 | 44 | 0.030 |
Why?
|
| Insecticide Resistance | 1 | 2013 | 11 | 0.030 |
Why?
|
| Bacterial Capsules | 1 | 2013 | 18 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 46 | 0.020 |
Why?
|
| Histidine Kinase | 1 | 2013 | 3 | 0.020 |
Why?
|
| Pigments, Biological | 1 | 2013 | 7 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 34 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2014 | 86 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2013 | 25 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 131 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 42 | 0.020 |
Why?
|
| Cytosol | 1 | 2014 | 185 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 67 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2012 | 41 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 44 | 0.020 |
Why?
|
| Fungi | 1 | 2013 | 62 | 0.020 |
Why?
|
| Insecticides | 1 | 2013 | 45 | 0.020 |
Why?
|
| Prion Proteins | 1 | 2012 | 7 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 69 | 0.020 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2012 | 5 | 0.020 |
Why?
|
| Virus Diseases | 2 | 2003 | 120 | 0.020 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2012 | 9 | 0.020 |
Why?
|
| Artemisinins | 1 | 2012 | 42 | 0.020 |
Why?
|
| Superoxides | 1 | 2012 | 73 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 1992 | 25 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2012 | 51 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2013 | 151 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 456 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 23 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 20 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2012 | 64 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 160 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 216 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1991 | 11 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1991 | 22 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1991 | 19 | 0.020 |
Why?
|
| Mice, Inbred CBA | 2 | 2002 | 80 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 395 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 285 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 100 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 465 | 0.020 |
Why?
|
| Imidazoles | 1 | 2012 | 86 | 0.020 |
Why?
|
| Haplorhini | 1 | 2011 | 14 | 0.020 |
Why?
|
| Indoles | 1 | 2012 | 119 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2012 | 83 | 0.020 |
Why?
|
| Necrosis | 1 | 2012 | 146 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 153 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2002 | 116 | 0.020 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 3 | 0.020 |
Why?
|
| Interferon Inducers | 1 | 2010 | 11 | 0.020 |
Why?
|
| Lipoprotein(a) | 1 | 2010 | 8 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2013 | 401 | 0.020 |
Why?
|
| Toll-Like Receptor 5 | 2 | 2000 | 11 | 0.020 |
Why?
|
| Poly I-C | 1 | 2010 | 76 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 1990 | 40 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 1990 | 17 | 0.020 |
Why?
|
| Feces | 1 | 2011 | 117 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 350 | 0.020 |
Why?
|
| Sirolimus | 1 | 2011 | 93 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 1216 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 87 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1991 | 211 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 1990 | 34 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2011 | 132 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 238 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2009 | 6 | 0.020 |
Why?
|
| Integrins | 1 | 1990 | 109 | 0.020 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2009 | 13 | 0.020 |
Why?
|
| Ribose | 1 | 2009 | 5 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1574 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 331 | 0.020 |
Why?
|
| RNA | 1 | 2013 | 432 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2004 | 524 | 0.020 |
Why?
|
| Epitopes | 2 | 2001 | 294 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 11 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2009 | 46 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2009 | 36 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1474 | 0.020 |
Why?
|
| Germ-Free Life | 1 | 2009 | 8 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2009 | 21 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2009 | 98 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2009 | 111 | 0.020 |
Why?
|
| Fever | 1 | 2009 | 68 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 1988 | 67 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 137 | 0.020 |
Why?
|
| Streptococcus mutans | 1 | 2008 | 4 | 0.020 |
Why?
|
| Periodontal Index | 1 | 2008 | 4 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2009 | 102 | 0.020 |
Why?
|
| Retroelements | 1 | 2008 | 44 | 0.020 |
Why?
|
| United States | 1 | 2021 | 8126 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2008 | 8 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 60 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2008 | 14 | 0.020 |
Why?
|
| Luciferases, Renilla | 1 | 2007 | 3 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2008 | 43 | 0.020 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2009 | 117 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2008 | 39 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2007 | 6 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1988 | 146 | 0.020 |
Why?
|
| Asparagine | 1 | 2007 | 25 | 0.020 |
Why?
|
| Half-Life | 1 | 1988 | 80 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2008 | 46 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1987 | 34 | 0.020 |
Why?
|
| Body Temperature | 1 | 1987 | 46 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2007 | 56 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 59 | 0.020 |
Why?
|
| Aeromonas | 1 | 1987 | 6 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1987 | 101 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Colon | 1 | 2009 | 151 | 0.020 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1987 | 19 | 0.020 |
Why?
|
| Glycosylation | 1 | 2007 | 139 | 0.020 |
Why?
|
| Trachea | 1 | 2007 | 84 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2007 | 25 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 295 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2007 | 148 | 0.020 |
Why?
|
| Wuchereria | 1 | 2007 | 2 | 0.020 |
Why?
|
| Rickettsiaceae Infections | 1 | 2007 | 5 | 0.020 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2006 | 6 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 106 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 71 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 261 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 83 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2008 | 112 | 0.020 |
Why?
|
| Peroxidase | 1 | 2007 | 70 | 0.020 |
Why?
|
| Virus Activation | 1 | 2006 | 23 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2007 | 108 | 0.020 |
Why?
|
| Symbiosis | 1 | 2007 | 39 | 0.020 |
Why?
|
| Blood Cells | 1 | 2006 | 17 | 0.020 |
Why?
|
| Self Tolerance | 1 | 2006 | 20 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1987 | 374 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1393 | 0.020 |
Why?
|
| Glycation End Products, Advanced | 1 | 2006 | 19 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 316 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2006 | 36 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2006 | 102 | 0.020 |
Why?
|
| Anthracenes | 1 | 2006 | 12 | 0.020 |
Why?
|
| Enterocolitis | 1 | 2006 | 3 | 0.020 |
Why?
|
| Bordetella bronchiseptica | 1 | 2005 | 2 | 0.010 |
Why?
|
| Bordetella parapertussis | 1 | 2005 | 2 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 23 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 93 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2005 | 11 | 0.010 |
Why?
|
| Nasopharynx | 1 | 2005 | 21 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2005 | 21 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2006 | 184 | 0.010 |
Why?
|
| Liver Failure, Acute | 1 | 2005 | 26 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2005 | 32 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2005 | 34 | 0.010 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2005 | 19 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 133 | 0.010 |
Why?
|
| Dogs | 1 | 2006 | 343 | 0.010 |
Why?
|
| S-Adenosylmethionine | 1 | 2005 | 31 | 0.010 |
Why?
|
| Corneal Stroma | 1 | 2005 | 11 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 185 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 37 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2005 | 149 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1987 | 526 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2004 | 16 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1157 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 631 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 5440 | 0.010 |
Why?
|
| Immunocompetence | 1 | 2004 | 21 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2005 | 124 | 0.010 |
Why?
|
| Virion | 1 | 2005 | 122 | 0.010 |
Why?
|
| Escherichia coli K12 | 1 | 2004 | 19 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2004 | 131 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 296 | 0.010 |
Why?
|
| Bombyx | 1 | 2004 | 10 | 0.010 |
Why?
|
| Acylation | 1 | 2004 | 17 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2004 | 24 | 0.010 |
Why?
|
| Vaccines, Conjugate | 1 | 2004 | 19 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 97 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2003 | 29 | 0.010 |
Why?
|
| Hepatitis C, Chronic | 1 | 2004 | 91 | 0.010 |
Why?
|
| Skin | 1 | 2007 | 424 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 171 | 0.010 |
Why?
|
| Brefeldin A | 1 | 2002 | 7 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2004 | 153 | 0.010 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2002 | 2 | 0.010 |
Why?
|
| Nystatin | 1 | 2002 | 3 | 0.010 |
Why?
|
| U937 Cells | 1 | 2002 | 10 | 0.010 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2002 | 2 | 0.010 |
Why?
|
| G(M1) Ganglioside | 1 | 2002 | 12 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 553 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2002 | 43 | 0.010 |
Why?
|
| Periodontium | 1 | 2002 | 1 | 0.010 |
Why?
|
| Fusobacterium nucleatum | 1 | 2002 | 4 | 0.010 |
Why?
|
| HIV-1 | 1 | 2007 | 727 | 0.010 |
Why?
|
| Freeze Drying | 1 | 2002 | 15 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2002 | 64 | 0.010 |
Why?
|
| Heterozygote | 1 | 2002 | 175 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 222 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2002 | 86 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2002 | 216 | 0.010 |
Why?
|
| Butadienes | 1 | 2001 | 13 | 0.010 |
Why?
|
| Octoxynol | 1 | 2001 | 11 | 0.010 |
Why?
|
| Chlamydophila Infections | 1 | 2001 | 6 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 81 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2002 | 65 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2001 | 44 | 0.010 |
Why?
|
| Detergents | 1 | 2001 | 34 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 49 | 0.010 |
Why?
|
| Nitriles | 1 | 2001 | 84 | 0.010 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2000 | 1 | 0.010 |
Why?
|
| Mesocricetus | 1 | 2001 | 96 | 0.010 |
Why?
|
| Flavonoids | 1 | 2001 | 75 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2001 | 52 | 0.010 |
Why?
|
| Glucuronic Acid | 1 | 2000 | 20 | 0.010 |
Why?
|
| Base Pair Mismatch | 1 | 2001 | 36 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 204 | 0.010 |
Why?
|
| Cation Transport Proteins | 1 | 2001 | 22 | 0.010 |
Why?
|
| Actins | 1 | 2002 | 263 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 94 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2000 | 13 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 2001 | 85 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 457 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2001 | 174 | 0.010 |
Why?
|
| Mannans | 1 | 1999 | 21 | 0.010 |
Why?
|
| Photoaffinity Labels | 1 | 1999 | 5 | 0.010 |
Why?
|
| Immune Sera | 1 | 1999 | 35 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1999 | 175 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1999 | 31 | 0.010 |
Why?
|
| Wasp Venoms | 1 | 1998 | 2 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 15 | 0.010 |
Why?
|
| Mammals | 1 | 2000 | 224 | 0.010 |
Why?
|
| Chemokine CXCL5 | 1 | 1998 | 9 | 0.010 |
Why?
|
| Fluorescence | 1 | 1999 | 93 | 0.010 |
Why?
|
| Proteins | 1 | 2004 | 764 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1998 | 157 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1999 | 421 | 0.010 |
Why?
|
| Tuberculosis | 1 | 2001 | 305 | 0.010 |
Why?
|
| Immunologic Capping | 1 | 1997 | 10 | 0.010 |
Why?
|
| Casein Kinase II | 1 | 1997 | 16 | 0.010 |
Why?
|
| Serine | 1 | 1997 | 92 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1997 | 70 | 0.010 |
Why?
|
| Codon | 1 | 1997 | 59 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 1995 | 19 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 1995 | 54 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1995 | 72 | 0.010 |
Why?
|
| CD3 Complex | 1 | 1995 | 64 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 20 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1995 | 15 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1995 | 155 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 30 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1995 | 263 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 1698 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 42 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1990 | 103 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1988 | 14 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1988 | 193 | 0.000 |
Why?
|
| Chromosomes, Bacterial | 1 | 1988 | 43 | 0.000 |
Why?
|
| Genes, Bacterial | 1 | 1988 | 120 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1988 | 297 | 0.000 |
Why?
|